| Name | Title | Contact Details |
|---|
Situated alongside Lake Champlain, we are the largest private non-profit human services organization in the State of Vermont. Since 1865, Howard Center has been helping people and communities thrive by providing supports and services to address mental health, substance use, and developmental needs. Today, we employ 1,600 staff providing services in 60 locations serving more than 16,000 community members annually. Through our competitive and award-winning benefits, work-life balance and equal opportunity employment, we build teams of dedicated, passionate individuals who embrace our mission and are committed to making a lasting contribution to the lives of the people we serve. The world around us continues to change every day. At Howard Center, we believe it is vital to face new and unanticipated obstacles with all of our voices. We welcome applicants of all racial and ethnic backgrounds, identities and expressions, religious beliefs, disabilities, age groups, lived experiences and perspectives. In order to provide the best care for our clients, our aim is for our staff to be a reflection of the community we serve.
Palo Pinto General Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Palo Pinto General Hospital is based in Mineral Wells, TX. You can find more information on Palo Pinto General Hospital at www.ppgh.com
Upright MRI of Cherry Hill is a Cherry Hill, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
DxNA is a St George, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.